Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions
Related Experiment Video
Updated: Jun 23, 2026

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software
Published on: December 14, 2020
Che Y O'May1, Kevin Sanderson1, Louise F Roddam1
1Menzies Research Institute, University of Tasmania Clinical School, 43 Collins Street, Hobart, Tasmania 7001, Australia.
Abstract:
The success of Pseudomonas aeruginosa in cystic fibrosis (CF) and other chronic infections is largely attributed to its ability to grow in antibiotic-resistant biofilm communities. This study investigated the effects of limiting iron levels as a strategy for preventing/disrupting P. aeruginosa biofilms. A range of synthetic and naturally occurring iron-chelating agents were examined. Biofilm development by P. aeruginosa strain PAO1 and CF sputum isolates from chronically infected individuals was significantly decreased by iron removal under aerobic atmospheres. CF strains formed poor biofilms under anaerobic conditions. Strain PAO1 was also tested under anaerobic conditions. Biofilm formation by this model strain was almost totally prevented by several of the chelators tested. The ability of synthetic chelators to impair biofilm formation could be reversed by iron addition to cultures, providing evidence that these effective chelating compounds functioned by directly reducing availability of iron to P. aeruginosa. In contrast, the biological chelator lactoferrin demonstrated enhanced anti-biofilm effects as iron supplementation increased. Hence biofilm inhibition by lactoferrin appeared to occur through more complex mechanisms to those of the synthetic chelators. Overall, our results demonstrate the importance of iron availability to biofilms and that iron chelators have potential as adjunct therapies for preventing biofilm development, especially under low oxygen conditions such as encountered in the chronically infected CF lung.
Insights
Limiting iron availability inhibits Pseudomonas aeruginosa biofilm formation, a key factor in chronic infections like cystic fibrosis (CF). Iron chelators show promise as therapies, particularly in low-oxygen environments found in CF lungs.
Area of Science:
- Microbiology
- Infectious Diseases
- Biochemistry
Background:
- Pseudomonas aeruginosa biofilms are crucial for antibiotic resistance in chronic infections, notably cystic fibrosis (CF).
- Iron availability is a critical factor influencing bacterial growth and biofilm formation.
- Understanding iron's role can reveal new therapeutic strategies against persistent infections.
Purpose of the Study:
- To investigate the efficacy of iron-limiting strategies in preventing or disrupting Pseudomonas aeruginosa biofilms.
- To evaluate various synthetic and natural iron-chelating agents against P. aeruginosa biofilms.
- To explore the impact of oxygen levels on iron chelation's anti-biofilm effects.
Main Methods:
- Tested synthetic and natural iron chelators on P. aeruginosa strain PAO1 and CF sputum isolates.
- Assessed biofilm development under both aerobic and anaerobic conditions.
- Investigated the reversibility of chelator effects by iron supplementation.
Main Results:
- Iron removal significantly decreased P. aeruginosa biofilm formation under aerobic conditions.
- CF strains exhibited poor biofilm formation anaerobically.
- Synthetic chelators' effects were reversed by iron addition, confirming iron deprivation as the mechanism.
- Lactoferrin showed enhanced anti-biofilm activity with increased iron, suggesting complex mechanisms.
Conclusions:
- Iron availability is essential for P. aeruginosa biofilm development.
- Iron chelators are potential adjunct therapies for preventing biofilms, especially in low-oxygen environments.
- Lactoferrin's anti-biofilm mechanism differs from synthetic chelators and warrants further investigation.
Related Concept Videos
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing
Microbial Corrosion
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Microbes and Other Elemental Cycles
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...

